This exploration was performed To guage the possible in the CPPs with tumor-concentrating on Homes to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, as a novel therapeutic method for CXCR4+ HCC cells. T22 was chosen as the nanocarrier https://aabyeq986vbf1.smblogsites.com/profile